News
News
Our company
选择年限
2023
更早
更晚
Our company
R&D Journey | From 49,000,000,000 to 1: China’s First AI-...
03
2026.09
30
2026.07
Our company
Breakthrough from 0 to 1: Mprosevir, an Original Anti-COV...
On July 29, 2026, Iscartrelvir Hydrochloride Tablets (brand name: Mprosevir ®), a Class 1 innovative drug jointly developed by Westlake Un...
阅读全文
18
2026.07
Our company
Westlake Pharma Secures Strategic Investment from Two Nan...
Shanghai, July 16— The "Smart Integration of Industry and Talent" Nantong Biopharmaceutical Industry Cooperation and Matchmaking Event, ...
阅读全文
24
2026.04
Our company
Continued Evolution: Westlake Pharma Once Again Named a H...
April 23, 2026 – The 10th All Blossom Conference, hosted by the Zhejiang Provincial Committee of the China National Democratic Construct...
阅读全文
12
2026.03
Our company
Westlake Pharma Founders Unveil DEL Screening Target Suit...
In the vast chemical space, efficiently and precisely identifying molecules capable of treating specific diseases stands as a core challenge i...
阅读全文
06
2026.01
Our company
Westlake Pharma Commences the New Year with Two Awards at...
January 4, 2026 – The Xihu District Technology Innovation Conference and the "296X" Advanced Manufacturing Cluster Promotion Meeting wer...
阅读全文
1
2
3
4
5